Nirmatrelvir Film-Coated Tablets

SECTION 2: Hazards identification

OSHA Classification of the substance or mixture

2.3 Other hazards

Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Nirmatrelvir Pfizer OEL TWA-8 Hr: PBT & vPvB 20 µg/m3 The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

Signal word

Not classified

Hazard statements

Not classified in accordance with international standards for workplace safety.

Supplemental label elements

Compound, not fully tested, additional hazards may exist. Unknown acute toxicity 15 - 20 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 15 - 20 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist).

2.1 Classification of the substance or mixture

GHS - Classification: This mixture is classified as not hazardous according to regulation (EC) 1272/2008 [CLP]. OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable